Document:

Exhibit 10.1

 

PURCHASE
AGREEMENT 

 

THIS
PURCHASE AGREEMENT (the “Agreement”), dated as of the 23rd day of June, 2021, by and
between USA Equities Corp., with its principal place of business at 901 Northpoint Parkway Suite 302, West Palm
Beach FL 33407 (the “Buyer”) and MedScience Research Group, Inc., a Florida corporation with its principal
place of business at 16469 Bridlewood Cir Delray Beach FL 33445 the “Seller”). The Buyer and the Seller are
sometimes referred to herein individually, as the “Party” and collectively, as the “Parties.”

 

WHEREAS,
the Seller owns the US Trademark “AllergiEnd”, Registration No. 4,618,114 (the “Mark”), the Web domain “AllergiEnd.com”
(the “Domain”), the US Method Patent Registration No. 9,655,556 (the “Patent”), together with the know-how and
intellectual property related to the inventions embodied in the Patent, together Seller’s “Intellectual Property”;
and

 

WHEREAS
the Buyer wishes to purchase and the Seller desires to sell, transfer and assign said Intellectual Property for the consideration
set forth in Article 2 below.

 

NOW,
THEREFORE, in consideration of the foregoing premises and the mutual representations, warranties, covenants, and agreements contained
herein, the adequacy and legal sufficiency of which are hereby acknowledged, the Parties hereby agree as follows:

 

ARTICLE
1

TRANSFER
of ASSETS

 

1.1
Transfer.

 

(a)
Seller hereby sells, assigns, transfers and delivers all right, title and interest of Seller in the Intellectual Property as set forth
above, as well as the goodwill associated with the Mark (collectively, the “Purchased Assets”) to Buyer, in each case free
and clear of all liens, claims and encumbrances as defined below.

 

(b)
Concurrently herewith Seller is delivering to Buyer a Bill of Sale for the Purchased Assets. Promptly after the date hereof Seller shall
execute and deliver such further instruments including a trademark assignment and patent assignment in such forms as are required to
transfer record ownership of the Mark and Patent to Buyer on the records of the US Patent and Trademark Office and shall execute and
deliver such additional documents, instruments, conveyances and assurances and take such further actions as may be reasonably required
to carry out the intent of this Agreement so as to give full effect to the transactions contemplated by this Agreement.

 

    	 

     

    

 

ARTICLE
2

CONSIDERATION

 

2.1
Consideration.

 

In consideration for acquiring
the Purchased Assets from Seller, at the Closing Buyer is delivering to Seller Buyer’s promissory note in the amount of $750,000.
The note shall bear simple interest at the rate of ten percent (10%) per annum (the “Note”) and shall be payable in thirty-six
consecutive equal monthly installments commencing the month following the date hereof. In addition, Buyer shall promptly after the
date hereof issue to Seller or its designees one million two hundred fifty thousand (1,250,000) restricted shares of Buyer’s common
stock, having a par value of $0.0001 (the “Shares”). Seller acknowledges that the Shares have not as yet been
registered under the Securities Act of 1933, as amended, and the certificate(s) shall bear a restrictive legend. Upon issuance pursuant
hereto, the Shares shall be duly issued, fully paid for and non-assessable.

 

ARTICLE
3

SELLER’
REPRESENTATIONS AND WARRANTIES

 

The
Seller hereby represents and warrants to Buyer as follows:

 

3.1
Organization, etc. Seller is a corporation duly organized, validly existing and in good standing under the laws of the State
of Delaware. The Seller has all requisite power to own, lease and operate all of its respective assets owned by it in connection with
the conduct of its business, as well as to sell, transfer and assign the herein described Purchased Assets.

 

3.2
Authorization. The Seller has all requisite power and authority to enter into, execute, deliver, and perform its obligations
under this Agreement and those other agreements and instruments required to be executed or delivered under this Agreement, and to perform
its obligations thereunder.

 

3.3
Good Title. The Seller owns the Purchased Assets and is delivering to Buyer, good, valid and marketable title to the Purchased
Assets, free and clear of all mortgages, pledges, security interests, liens (including tax liens), charges, options or other encumbrances
of any nature whatsoever (collectively, the “Encumbrances”).

 

3.4
Consents and Approvals. No consent, approval, order or authorization of or from, or registration, notification, declaration
or filing with any individual or entity is required in connection with the performance of this Agreement by the Seller or the consummation
by the Seller and Buyer of the transactions contemplated herein.

 

ARTICLE
4

BUYER’S
REPRESENTATIONS AND WARRANTIES

 

Buyer
hereby represents and warrants to the Seller as follows:

 

4.1
Authorization and Power. Buyer has all power and authority to enter into this Agreement and to carry out the transactions
contemplated herein. This Agreement is the valid and binding legal obligation of Buyer enforceable against Buyer in accordance with its
terms.

 

    	 

     

    

 

4.2
Good Standing. The Buyer is a corporation duly organized, validly existing and in good standing under the laws of the State
of Delaware with the requisite corporate power and authority to carry on its business as it is now being conducted and to own, operate
and lease its properties and assets.

 

4.3
Authorization. The Buyer has all requisite power and authority to enter into, execute, deliver, and perform its obligations
under this Agreement and those other agreements and instruments required to be executed or delivered under this Agreement, and to perform
its obligations thereunder.

 

4.4
Non-Contravention. Neither the execution, delivery nor performance of this Agreement and each other transaction document nor
the consummation of the transactions contemplated hereby or thereby will be in conflict with, or constitute a default, however defined
(or an event which, with the giving of due notice or lapse of time, or both, would constitute such a default), under any agreement to
which Buyer is a party; or violate any law.

 

4.5
Consents and Approvals. No consent is required by any person or entity in connection with the execution, delivery and performance
by Buyer of its obligation under the Agreement or the consummation of the transactions contemplated herein.

 

ARTICLE
5

INDEMNIFICATION

 

5.1
Survival of Representations and Warranties. The representations and warranties of the Parties contained herein or in any signed writing
delivered in connection with this Agreement will survive for a period of one (1) year after the execution of this Agreement.

 

5.2
Seller’s Indemnification. The Seller will indemnify Buyer and its officers, directors, agents and representatives, in their
capacities as such, and the successors, heirs and personal representatives of any of them (collectively, the “Buyer Indemnified
Parties”) against and hold them harmless from any and all damage, loss, liability and expense (including, without limitation,
reasonable expenses of investigation and attorneys’ fees and expenses) (collectively “Loss”) incurred
or suffered by any Buyer Indemnified Party arising out of or relating to any breach of any representation, warranty, covenant or other
agreement of the Seller contained herein, provided a claim for indemnification is made within one year of the execution of this Agreement.

 

    	 

     

    

 

5.3
Buyer’s Indemnification. The Buyer will indemnify Seller and its officers, directors, agents and representatives, in their
capacities as such, and the successors, heirs and personal representatives of any of them (collectively, the “Seller Indemnified
Parties”) against and hold them harmless from any and all damage, loss, liability and expense (including, without limitation,
reasonable expenses of investigation and attorneys’ fees and expenses) (collectively “Loss”) incurred
or suffered by any Seller Indemnified Party arising out of or relating to any breach of any representation, warranty, covenant or other
agreement of the Buyer contained herein, provided a claim for indemnification is made within one year of the execution of this Agreement.

 

ARTICLE
6

MISCELLANEOUS
PROVISIONS

 

6.1
Expenses. Buyer and the Seller will each bear their own costs and expenses relating to the transactions contemplated hereby, including
without limitation, fees and expenses of legal counsel, accountants, finders, consultants or other representatives for the services used,
hired or connected with the transactions contemplated hereby. Neither Buyer nor any Seller will charge any of his expenses to any other
Party or seek reimbursement from any Party for any of its expenses, except Buyer shall be responsible for all costs associated with the
transfer and registration of any of the Intellectual Property with either the U.S. Patent and Trademark office or any other governmental
agency involved with the registration and recognition of such properties.

 

6.2
Amendment and Modification. Subject to applicable law, this Agreement may be amended or modified by the Parties at any time with
respect to any of the terms contained herein; provided, however, that all such amendments and modifications must be in writing
duly executed by all of the Parties hereto.

 

6.3
Waiver of Compliance; Consents. Any failure of a Party to comply with any obligation, covenant, agreement or condition herein may
be expressly waived in writing by the Party entitled hereby to such compliance, but such waiver or failure to insist upon strict compliance
with such obligation, covenant, agreement or condition will not operate as a waiver of, or estoppel with respect to, any subsequent or
other failure. No single or partial exercise of a right or remedy will preclude any other or further exercise thereof or of any other
right or remedy hereunder. Whenever this Agreement requires or permits the consent by or on behalf of a Party, such consent will be given
in writing in the same manner as for waivers of compliance.

 

6.4
No Third Party Beneficiaries. Nothing in this Agreement will entitle any person or entity (other than a Party hereto and its respective
successors and assigns permitted hereby) to any claim, cause of action, remedy or right of any kind.

 

    	 

     

    

 

6.5
Notices. All notices, requests, demands and other communications required or permitted hereunder will be made in writing and will
be deemed to have been duly given and effective: (i) on the date of delivery, if delivered personally; (ii) on the earlier of the fourth
(4th) day after mailing or the date of the return receipt acknowledgement, if mailed, postage prepaid, by certified or registered mail,
return receipt requested; or (iii) on the date of transmission, if sent by facsimile, telecopy, telegraph, telex or other similar telegraphic
communications equipment, or to such other person or address as the Parties hereto in writing in accordance with this subsection, as
follows:

 

	 	If
    to Buyer, then to:
	 	 
	 	USA
    Equities Corp
	 	Attn:
    Troy Grogan, President
	 	901
    Northpoint Parkway Suite 302 West Palm Beach FL 33407
	 	Telephone:
    (929) 379-6503
	 	 
	 	If
    to Seller, then to:
	 	 
	 	MedScience
    Research Group, Inc. 
	 	Attn:
    Marvin Smollar, President
	 	16469
    Bridlewood Cir Delray Beach FL 33445
	 	Telephone:
    (561) 515-5995

 

 

or
to such other persons or addresses as Buyer and Seller will furnish to the other in writing in accordance with this Agreement.

 

6.6
Assignment. This Agreement and all of the provisions hereof will be binding upon and inure to the benefit of the Parties and their
respective successors and permitted assigns, but neither this Agreement nor any of the rights, interests or obligations hereunder will
be assigned (whether voluntarily, involuntarily, by operation of law or otherwise) by any Seller without the prior written consent of
Buyer.

 

6.7
Governing Law. This Agreement will be governed by and construed in accordance with the laws of the State of Florida without regard
to its conflict of law rules, principles or provisions of such state or of any other state. The sole jurisdiction and venue for any litigation
arising out of this Agreement will be an appropriate federal or district court located in Palm Beach County of the State of Florida,
and each Party hereby consents to such jurisdiction.

 

6.8
Counterparts. This Agreement may be executed simultaneously in one or more counterparts, each of which will be deemed an original,
but all of which together will constitute one and the same instrument.

 

6.9
Facsimile and Scanned Execution. Receipt by either Party of a counterpart of this Agreement manually signed and then scanned electronically
and E-mailed to the other Party or manually signed and then sent by facsimile transmission to the other Party shall, for all purposes,
be deemed to be an original counterpart with the same force and effect as the manually signed counterpart from which it was electronically
reproduced.

 

6.10
Entire Agreement. This Agreement and the exhibits and other writings referred to in this Agreement or in any such exhibit or other
writing are part of this Agreement, together they embody the entire agreement and understanding of the Parties hereto in respect of the
transactions contemplated by this Agreement and together they are referred to as this Agreement or the transactions contemplated hereby.
There are no restrictions, promises, warranties, agreements, covenants or undertakings, other than those expressly set forth or referred
to in this Agreement. This Agreement supersedes all prior agreements and understandings between the Parties with respect to the transaction
or transactions contemplated by this Agreement. Provisions of this Agreement will be interpreted to be valid and enforceable under applicable
Law to the extent that such interpretation does not materially alter this Agreement; provided, however, that if any such provision
becomes invalid or unenforceable under applicable Law such provision will be stricken to the extent necessary and the remainder of such
provisions and the remainder of this Agreement will continue in full force and effect.

 

6.11
No Broker or Finder. Neither the Seller or Buyer has employed any broker, finder, investment banker or financial advisor or
incurred any liability for any brokerage fee or commission, finder’s fee or financial advisory fee, in connection with the transactions
contemplated hereby, nor is there any basis known to Seller or Buyer for any such fee or commission to be claimed by any person or entity.

 

(Signatures
on Following Page)

 

    	 

     

    

 

	USA
    Equities Corp as Buyer	 
	 	 	 
	By:	/s/
Troy Grogan	 
	Troy
    Grogan, as President and Principal Shareholder,	 
	Respectively	 
	 	 	 
	Date:	June
    23, 2021	 
	 	 	 
	MedScience
    Research Group, Inc., as Seller 	 
	 	 	 
	 	 	 
	By:	/s/
Marvin Smollar	 
	Marvin
    Smollar, President	 
	 	 	 
	Date:	June
    23, 2021	 

 

    	 

     

    

 

EXHIBIT
1

 

	 	US
    Method Patent “Method of Testing for Allergies” Number 9,655,556 B2
	 	 
	 	US
    Trademark “AllergiEnd” Reg. No. 4,618,114
	 	 
	 	Web
    Domain “AllergiEnd.com”Exhibit 10.2

 

PROMISSORY
NOTE

 

	$750,000	June 23,
    2021

 

FOR
VALUE RECEIVED, USA Equities Corp. (the “Maker”), promises to pay to MedScience Research Group, Inc., a Florida corporation
with its principal place of business at 16469 Bridlewood Circle, Delray Beach, Florida 33445, the principal sum of seven hundred fifty
thousand ($750,000) dollars, together with interest thereon at the rate of ten per cent (10%) per annum, which shall be payable in thirty-six
(36) equal consecutive monthly instalments of $24,200.39 commencing on the 7th day of July 2021 and continuing on the 7th
day of each month thereafter, to and including June 7, 2024 (the “Maturity Date”).

 

Upon
the occurrence and during the continuance of an Event of Default, Maker shall pay interest hereon at the rate of fifteen per cent (15%)
per annum. In no event shall the Holder hereof, or any permitted successor or assign, be entitled to receive, collect or retain any amount
of interest paid hereon in excess of that permitted by applicable law. The Maker shall have the right, at any time and from time to time,
upon three business days’ notice to the Holder, to prepay this Note in whole or in part together with accrued interest on
the amount prepaid, but without premium or penalty. All payments to Holder shall be made in United States dollars.

 

The
Maker agrees to pay on demand all reasonable costs and expenses in connection with the preparation, execution, delivery, administration,
modification, amendment and enforcement (whether through legal proceedings, negotiations or otherwise) of this Note and any other document
to be delivered hereunder (such costs and expenses shall include without limitation, the reasonable fees and expenses of legal counsel.)
The obligations of the Maker under this Paragraph shall survive the payment in full of this Note.

 

The
occurrence of any of the following events shall constitute a default (“Event of Default”):

 

(i)
Failure to Pay Principal or Interest. Maker fails to pay any installment of principal, interest or other sum due under this Note
within ten (10) days of the due date thereof;

 

(ii)
Receiver or Trustee. Maker or Guarantor shall make an assignment for the benefit of creditors or apply for or consent to the appointment
of a receiver or trustee for it him, or for a substantial part of its or his property or business; or such a receiver or trustee shall
otherwise be appointed without the consent of Maker of Guarantor and is not dismissed within sixty (60) days of appointment;

 

(iii)
Bankruptcy. Bankruptcy, insolvency, reorganization or liquidation proceedings or other proceedings or relief under any bankruptcy
law or any law, or the issuance of any notice in relation to such event, for the relief of debtors shall be instituted by or against
Maker or Guarantor and if instituted against Maker or Guarantor are not dismissed within sixty (60) days of initiation; and

 

    	1

    	 

    

 

(iv)
Judgements. One or more judgements for the payment of money in an aggregate amount in excess of $50,000 shall be rendered against
the Maker and shall remain undischarged for ten days during which execution shall not be effectively stayed.

 

Upon
the occurrence and during the continuance of any Event of Default, upon notice to Maker (except in the event of the failure to pay amounts
due as provided above), the Holder may demand the payment of the unpaid principal amount due hereunder, which together with all interest
accrued thereon and other amounts payable hereunder, shall become immediately due and payable, without presentment, demand, protest or
notice of any kind, all of which are hereby expressly waived, and the Holder may immediately enforce any and all of the Holder’s
rights and remedies provided herein or any other rights or remedies afforded by law.

 

The
Maker hereby waives presentment for payment, demand, notice of dishonor and protest of this Note. This Note shall be governed by, and
construed in accordance with, the laws of the State of Florida. None of the terms or provisions of this Note may be waived, altered,
modified or amended except as the Holder may consent thereto in writing.

 

Without
limiting the right of the Holder to bring any action or proceeding against the Maker or against property of the Maker arising out of
or relating to this Note (an “Action”) in the courts of other jurisdictions, the Maker hereby irrevocably submits to the
jurisdiction of any Florida or Federal Court sitting in Palm Beach County, Florida, respectively, and the Maker hereby irrevocably agrees
that any Action may be heard and determined in any such State or Federal court.

 

Any
notice or other communication required or permitted to be given to the Maker hereunder shall be in writing and shall be sent by Express
Mail or by a recognized overnight delivery courier service to the Maker at 901 Northpoint Parkway Suite 302 West Palm Beach Florida 33407,
Attn: President or to such other address as the Maker shall have furnished in writing in accordance with the provisions of this Note.
Any notice or other communication given by the means permitted hereunder shall be deemed given and effective two days after deposit thereof
with the United States Post Office or with a recognized overnight courier.

 

	 	USA
    Equities Corp.
	 	 	 
	 	By:	 /s/
    Troy Grogan
	 	 	Troy
Grogan
	 	 	President

 

    	2

    	 

    

 

Amortization
Schedule

 

	 	1	 	 	 	7/7/2021	 	 	$	750,000.00	 	 	$	24,200.39	 	 	$	17,950.39	 	 	$	6,250.00	 	 	$	732,049.61	 
	 	2	 	 	 	8/7/2021	 	 	$	732,049.61	 	 	$	24,200.39	 	 	$	18,099.98	 	 	$	6,100.41	 	 	$	713,949.63	 
	 	3	 	 	 	9/7/2021	 	 	$	713,949.63	 	 	$	24,200.39	 	 	$	18,250.81	 	 	$	5,949.58	 	 	$	695,698.82	 
	 	4	 	 	 	10/7/2021	 	 	$	695,698.82	 	 	$	24,200.39	 	 	$	18,402.90	 	 	$	5,797.49	 	 	$	677,295.92	 
	 	5	 	 	 	11/7/2021	 	 	$	677,295.92	 	 	$	24,200.39	 	 	$	18,556.26	 	 	$	5,644.13	 	 	$	658,739.66	 
	 	6	 	 	 	12/7/2021	 	 	$	658,739.66	 	 	$	24,200.39	 	 	$	18,710.89	 	 	$	5,489.50	 	 	$	640,028.77	 
	 	7	 	 	 	1/7/2022	 	 	$	640,028.77	 	 	$	24,200.39	 	 	$	18,866.82	 	 	$	5,333.57	 	 	$	621,161.95	 
	 	8	 	 	 	2/7/2022	 	 	$	621,161.95	 	 	$	24,200.39	 	 	$	19,024.04	 	 	$	5,176.35	 	 	$	602,137.91	 
	 	9	 	 	 	3/7/2022	 	 	$	602,137.91	 	 	$	24,200.39	 	 	$	19,182.57	 	 	$	5,017.82	 	 	$	582,955.34	 
	 	10	 	 	 	4/7/2022	 	 	$	582,955.34	 	 	$	24,200.39	 	 	$	19,342.43	 	 	$	4,857.96	 	 	$	563,612.91	 
	 	11	 	 	 	5/7/2022	 	 	$	563,612.91	 	 	$	24,200.39	 	 	$	19,503.62	 	 	$	4,696.77	 	 	$	544,109.29	 
	 	12	 	 	 	6/7/2022	 	 	$	544,109.29	 	 	$	24,200.39	 	 	$	19,666.15	 	 	$	4,534.24	 	 	$	524,443.15	 
	 	13	 	 	 	7/7/2022	 	 	$	524,443.15	 	 	$	24,200.39	 	 	$	19,830.03	 	 	$	4,370.36	 	 	$	504,613.12	 
	 	14	 	 	 	8/7/2022	 	 	$	504,613.12	 	 	$	24,200.39	 	 	$	19,995.28	 	 	$	4,205.11	 	 	$	484,617.84	 
	 	15	 	 	 	9/7/2022	 	 	$	484,617.84	 	 	$	24,200.39	 	 	$	20,161.91	 	 	$	4,038.48	 	 	$	464,455.93	 
	 	16	 	 	 	10/7/2022	 	 	$	464,455.93	 	 	$	24,200.39	 	 	$	20,329.92	 	 	$	3,870.47	 	 	$	444,126.00	 
	 	17	 	 	 	11/7/2022	 	 	$	444,126.00	 	 	$	24,200.39	 	 	$	20,499.34	 	 	$	3,701.05	 	 	$	423,626.66	 
	 	18	 	 	 	12/7/2022	 	 	$	423,626.66	 	 	$	24,200.39	 	 	$	20,670.17	 	 	$	3,530.22	 	 	$	402,956.49	 
	 	19	 	 	 	1/7/2023	 	 	$	402,956.49	 	 	$	24,200.39	 	 	$	20,842.42	 	 	$	3,357.97	 	 	$	382,114.07	 
	 	20	 	 	 	2/7/2023	 	 	$	382,114.07	 	 	$	24,200.39	 	 	$	21,016.11	 	 	$	3,184.28	 	 	$	361,097.97	 
	 	21	 	 	 	3/7/2023	 	 	$	361,097.97	 	 	$	24,200.39	 	 	$	21,191.24	 	 	$	3,009.15	 	 	$	339,906.73	 
	 	22	 	 	 	4/7/2023	 	 	$	339,906.73	 	 	$	24,200.39	 	 	$	21,367.83	 	 	$	2,832.56	 	 	$	318,538.89	 
	 	23	 	 	 	5/7/2023	 	 	$	318,538.89	 	 	$	24,200.39	 	 	$	21,545.90	 	 	$	2,654.49	 	 	$	296,992.99	 
	 	24	 	 	 	6/7/2023	 	 	$	296,992.99	 	 	$	24,200.39	 	 	$	21,725.45	 	 	$	2,474.94	 	 	$	275,267.54	 
	 	25	 	 	 	7/7/2023	 	 	$	275,267.54	 	 	$	24,200.39	 	 	$	21,906.49	 	 	$	2,293.90	 	 	$	253,361.05	 
	 	26	 	 	 	8/7/2023	 	 	$	253,361.05	 	 	$	24,200.39	 	 	$	22,089.05	 	 	$	2,111.34	 	 	$	231,272.00	 
	 	27	 	 	 	9/7/2023	 	 	$	231,272.00	 	 	$	24,200.39	 	 	$	22,273.12	 	 	$	1,927.27	 	 	$	208,998.88	 
	 	28	 	 	 	10/7/2023	 	 	$	208,998.88	 	 	$	24,200.39	 	 	$	22,458.73	 	 	$	1,741.66	 	 	$	186,540.15	 
	 	29	 	 	 	11/7/2023	 	 	$	186,540.15	 	 	$	24,200.39	 	 	$	22,645.89	 	 	$	1,554.50	 	 	$	163,894.26	 
	 	30	 	 	 	12/7/2023	 	 	$	163,894.26	 	 	$	24,200.39	 	 	$	22,834.60	 	 	$	1,365.79	 	 	$	141,059.65	 
	 	31	 	 	 	1/7/2024	 	 	$	141,059.65	 	 	$	24,200.39	 	 	$	23,024.89	 	 	$	1,175.50	 	 	$	118,034.76	 
	 	32	 	 	 	2/7/2024	 	 	$	118,034.76	 	 	$	24,200.39	 	 	$	23,216.77	 	 	$	983.62	 	 	$	94,817.99	 
	 	33	 	 	 	3/7/2024	 	 	$	94,817.99	 	 	$	24,200.39	 	 	$	23,410.24	 	 	$	790.15	 	 	$	71,407.75	 
	 	34	 	 	 	4/7/2024	 	 	$	71,407.75	 	 	$	24,200.39	 	 	$	23,605.33	 	 	$	595.06	 	 	$	47,802.42	 
	 	35	 	 	 	5/7/2024	 	 	$	47,802.42	 	 	$	24,200.39	 	 	$	23,802.04	 	 	$	398.35	 	 	$	24,000.39	 
	 	36	 	 	 	6/7/2024	 	 	$	24,000.39	 	 	$	24,200.39	 	 	$	24,000.39	 	 	$	200.00	 	 	$	0.00	 

 

    	3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}]]